A TRPV1 antagonist is well tolerated and can improve dry eye disease symptoms and clinical signs as early as week 1, a Phase 2b study shows.
A predictive nomogram may help clinicians personalize myopia management for children at risk for axial lengths greater than ...
An AI-based retinal imaging model outperforms standard cardiovascular risk calculators in patients with hypertensive retinopathy.